Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Webinar presenter Tabetha Sundin, PhD, HCLD, MB, Sentara Healthcare, Scientific Director, discusses advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This on-demand webinar originally broadcast on October 3, 2018.
CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special grant from Bristol-Myers Squibb. IOUS1802863-01